| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/20/2011 | CN102131504A Combinations comprising bicyclic S1P lyase inhibitors |
| 07/20/2011 | CN102131502A Nutritional composition for improving mammalian immune system |
| 07/20/2011 | CN102131498A Composition comprising somatotrophic hormone |
| 07/20/2011 | CN102131497A Preparation and iontophorectic device for transdermal application of active ingredients |
| 07/20/2011 | CN102131483A Non-polymeric compositions for controllable drug delivery |
| 07/20/2011 | CN102127549A Children antimicrobial peptides Cathelicidins and preparation method and applications thereof |
| 07/20/2011 | CN102127163A Cloning, protein expression, polyclonal antibody preparation and use of nuclear factor TDRP1 |
| 07/20/2011 | CN102127161A Antitumor polypeptide and application thereof |
| 07/20/2011 | CN102127160A Scorpion active polypeptides as well as preparation method and application thereof |
| 07/20/2011 | CN102127154A A54-GFLG-DOX conjugate as well as coupling method and application thereof |
| 07/20/2011 | CN102127152A Antagonistic peptide of anti-opioid peptide and application thereof |
| 07/20/2011 | CN102127151A Antagonistic peptide of anti-opioid peptide and application thereof |
| 07/20/2011 | CN102127147A Mimotope of epidermal growth factor receptor (EGFR) and use thereof |
| 07/20/2011 | CN102127146A Method for preparing atosiban acetate |
| 07/20/2011 | CN102127145A Substituted tetrahydroisoquinoline compound as well as preparation method and application thereof |
| 07/20/2011 | CN102127141A Esculentoside A, EsA as well as preparation method and application thereof |
| 07/20/2011 | CN102125686A Application of hard clam polypeptide |
| 07/20/2011 | CN102125557A Use of flibanserin in the treatment of sexual disorders |
| 07/20/2011 | CN102125520A Emulsion containing hydrophilic biological macromolecule, preparation method and application thereof |
| 07/20/2011 | CN102125178A Feed additive for preventing and treating virus caused death of aquatic livestock and preparation method thereof |
| 07/20/2011 | CN101721349B Injectable in-situ crosslinking aquogel and preparation method and application thereof |
| 07/20/2011 | CN101700233B Method for preparing gonadorelin freeze-dried powder injection |
| 07/20/2011 | CN101648992B Small peptide B with antibacterial and antitumor functions and applications thereof |
| 07/20/2011 | CN101638432B Rana pleuraden antioxidant peptide and genes |
| 07/20/2011 | CN101507706B Biodegradable in-situ solidification sustained-release injector |
| 07/20/2011 | CN101491498B aFGF liposome, preparation method and use thereof |
| 07/20/2011 | CN101460138B Hair growth composition |
| 07/20/2011 | CN101449659B Environment regulating agent and production method thereof |
| 07/20/2011 | CN101113172B Anti-opium peptide and antagonistic peptide and its application |
| 07/20/2011 | CN101028509B Snake gallbladder for artificial medicine |
| 07/19/2011 | US7982066 High protein supplement |
| 07/19/2011 | US7982023 Bag proteins and nucleic acid molecules encoding them |
| 07/19/2011 | US7982018 conjugate urocortin polypeptide complexing with serum protein; increased in vivo half-life; cardiovascular disorder, stress or anxiety disorder, memory or learning disorder, obesity or anorexia eating disorder, decreasing body weight, glycemic control in gastrointestinal, modulating muscle mass |
| 07/19/2011 | US7982014 FGFR3-IIIc fusion proteins |
| 07/19/2011 | US7982010 Factor VIII polymer conjugates |
| 07/19/2011 | US7982008 antiinflammatory agents; anticancer agents; ulitization phosphate acceptor compound; phosphoprotein |
| 07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 07/19/2011 | US7982003 Creating designer antimicrobials; peptidoglycan hydrolase module shuffling |
| 07/19/2011 | US7982000 Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 07/19/2011 | US7981997 Growth factor which acts through ErbB-4 RTK |
| 07/19/2011 | US7981873 Use within transplantation surgery |
| 07/19/2011 | US7981868 Antisense oligonucleotide chemically modified with a phosphorothioate linkage, a 2'-O-methoxyethyl modified sugar, or 5-methylated cytosine; antiinflammatory agents that reduce mucus production in airways |
| 07/19/2011 | US7981867 Use of des-aspartate-angiotensin I |
| 07/19/2011 | US7981866 MG53 compositions and methods of use |
| 07/19/2011 | US7981865 Antigenic fragments of human factor VIII polypeptides |
| 07/19/2011 | US7981864 Lysosomal enzyme fusion comprising mannose-6-phosphate receptor targeting immunoglobulin component for use in treatment of lysosomal storage diseases |
| 07/19/2011 | US7981863 Administering platelet derived growth factor, endothelial growth factor or a combination to modulate neural stem cell or neural porgenitor cell activity in vivo to a patient suffering from nerveous system disorder or disease |
| 07/19/2011 | US7981862 Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis |
| 07/19/2011 | US7981861 Method of performing angioplasty with a GLP-1 molecule |
| 07/19/2011 | US7981860 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation |
| 07/19/2011 | US7981859 Including teicoplanin which shares many chemical and microbiological characteristics with vancomycin, but which possesses higher activity against many Gram-positive bacteria and is less nephrotoxic |
| 07/19/2011 | US7981858 Methods of using zinc containing compounds to improve ocular health |
| 07/19/2011 | US7981857 Cerberus/coco derivatives and uses thereof |
| 07/19/2011 | US7981691 Polypeptide comprising staphylococcal protein a/b domains for use as fusion components for directing immunoglobulins to preferential targets; |
| 07/19/2011 | US7981676 Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 07/19/2011 | US7981674 Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation |
| 07/19/2011 | US7981673 Process for the maturation of dendritic cells and a vaccine |
| 07/19/2011 | US7981669 Viral vectors |
| 07/19/2011 | US7981660 Methods for producing modified glycoproteins |
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981623 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
| 07/19/2011 | US7981614 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/19/2011 | US7981598 Preventive/remedy for respiratory diseases |
| 07/19/2011 | US7981596 Tissue preservation with a salt solution isotonic with interstitial fluids |
| 07/19/2011 | US7981432 Proteins within the type E botulinum neurotoxin complex |
| 07/19/2011 | US7981427 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43 |
| 07/19/2011 | US7981426 Method for stimulating wound healing |
| 07/19/2011 | US7981425 Thrombopoietic compounds |
| 07/19/2011 | US7981424 RAGE fusion proteins, formulations, and methods of use thereof |
| 07/19/2011 | US7981423 Rage fusion proteins |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981419 Method for treating hypophosphatemic bone diseases using FGF-23 antibody |
| 07/19/2011 | US7981417 Blood-brain barrier targeting anti-bodies |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | US7981409 Method of reducing aging of skin by applying interleukin-1 alpha |
| 07/19/2011 | US7981406 Compositions for accelerating the production of collagen-containing proteins |
| 07/19/2011 | US7981400 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors |
| 07/19/2011 | CA2637774C Nucleosides with anti-hepatitis b virus activity |
| 07/19/2011 | CA2565195C Antimicrobial polypeptides |
| 07/19/2011 | CA2473218C Disease susceptibility gene for rheumatoid arthritis, protein thereof, evaluation method and evaluation kit for evaluating onset possibility of rheumatoid arthritis by using those, and remedy and curing medicine for rheumatoid arthritis |
| 07/19/2011 | CA2440890C Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 07/19/2011 | CA2401906C Kcnb: a novel potassium channel protein |
| 07/19/2011 | CA2400403C 1-nitroacridine/tumor inhibitor compositions |
| 07/19/2011 | CA2398155C Methods and compositions for linking binding domains in nucleic acid binding proteins |
| 07/19/2011 | CA2397354C O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/19/2011 | CA2336445C Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/19/2011 | CA2281952C Compounds for immunotherapy of prostate cancer and methods for their use |
| 07/19/2011 | CA2220555C Methods and compositions for healing and repair of connective tissue attachment |
| 07/19/2011 | CA2188560C Compositions comprising dna damaging agents and p53 |
| 07/19/2011 | CA2185656C Protein tyrosine kinase agonist antibodies |
| 07/19/2011 | CA1341618C Isolation cloning and expression of primate gm-csf |
| 07/14/2011 | WO2011085393A1 Stable insulin formulations and methods of making and using thereof |
| 07/14/2011 | WO2011085354A1 Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma |
| 07/14/2011 | WO2011085301A1 Biomatrices to attract and retain regenerative and reparative cells |
| 07/14/2011 | WO2011085231A2 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
| 07/14/2011 | WO2011085110A1 Apoe peptide dimers and uses thereof |
| 07/14/2011 | WO2011085070A2 Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts |
| 07/14/2011 | WO2011084967A2 Methods and compositions for providing protective immunity in the elderly |
| 07/14/2011 | WO2011084964A1 Methods for increasing expression of serca2a in cardiac muscle |